TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05637346

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intra-operative ultrasound measurement
Description: A patient-specific 3D model will be created using an available pre-operative CT scan. Anatomical target points are selected on this virtual model before the start of the surgery. Prior to surgery, a patient-reference electromagnetic (EM) sensor will be placed between the patient and the matrass on the operating table to account for patient movement during acquisition. Intra-operatively, an initial point registration of the 3D model with the electromagnetic tracking system (EMTS) will be performed based on ultrasound (US) imaging of the arterial bifurcations by the surgeon. Then, the surgeon will acquire multiple US sweeps of the pelvic arteries (abdominal aorta and left and right iliac arteries). For validation purposes, the pre-operatively defined anatomical target points will be visualized on US imaging and by pinpointing the EM tracked pointer. All tracking and US data will be recorded and stored for post-operative analysis.
Study: NCT03451487

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Panadol®
Description: Acetaminophen 500mg Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SafeTynadol®
Description: Acetaminophen 500mg Tablet
Study: NCT05316883

Intervention type: DRUG
Group type: OTHER
Intervention: Clozapine
Description: clinical doses adjusted to sideeffects and clinical effect
Study: NCT05131243

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chemotherapy time
Description: 6 months of chemotherapy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy time
Description: 3 months of chemotherapy
Study: NCT05045014

Intervention type: OTHER
Intervention: Balance assessment
Description: Romberg test and one-leg standing test will be used.

Intervention type: OTHER
Intervention: Unterberger test
Description: During 50 steps, he will count in place with 45 degrees of hip flexion, and after 50 steps, the angle of rotation between the first position and the final position of the right foot will be measured with the help of a goniometer and the displacement distance.
Study: NCT04981496

Intervention type: OTHER
Intervention: Observational Study during Clinical and Simulated arrhythmias in patients with ICDs
Description: Observational Study during Clinical and Simulated arrhythmias in patients with ICDs

Intervention type: OTHER
Intervention: Observational Study during Clinical and Simulated arrhythmias in patients with ICDs
Description: Observational Study during Clinical and Simulated arrhythmias in patients with ICDs
Study: NCT06379724

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: 100mg/mL 10mL vials x2 of injectable tranexamic acid will be filled into a 20 milliliter syringe with a spray tip.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thrombin JMI
Description: The wound base is then sprayed with a film of Thrombin-JMI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: skin graft
Description: Skin is taken from uninjured part of the participant's body and used to surgically cover a wound or injured area with skin that contains the epidermis and a portion of the dermis.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: skin graft
Description: Skin is taken from uninjured part of the participant's body and used to surgically cover a wound or injured area with skin that contains the epidermis and a portion of the dermis.
Study: NCT06197373

Intervention type: PROCEDURE
Intervention: Laparoscopic cholecystectomy
Description: Doing laparoscopic cholecystectomy after ERCP at different intervals

Intervention type: PROCEDURE
Intervention: Laparoscopic cholecystectomy
Description: Doing laparoscopic cholecystectomy after ERCP at different intervals
Study: NCT05045014

Intervention type: OTHER
Intervention: Unterberger test
Description: During 50 steps, he will count in place with 45 degrees of hip flexion, and after 50 steps, the angle of rotation between the first position and the final position of the right foot will be measured with the help of a goniometer and the displacement distance.

Intervention type: OTHER
Intervention: Corsi Block Tapping (mobıl app)
Description: Spatial memory will be evaluated.

Intervention type: OTHER
Intervention: Corsi Block Tapping (mobıl app)
Description: Spatial memory will be evaluated.
Study: NCT03451487

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SafeTynadol®
Description: Acetaminophen 500mg Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SafeTynadol®
Description: Acetaminophen 500mg Tablet
Study: NCT05045014

Intervention type: OTHER
Intervention: Navigation performance
Description: Two triangles (one equilateral, one oblique triangle, at 30°, 60° and 90° angles respectively) with route segment lengths between 150 and 300 cm will be marked on the floor and the participants will be asked to complete the task with their eyes closed. The final deviation amount will be recorded.

Intervention type: OTHER
Intervention: Navigation performance
Description: Two triangles (one equilateral, one oblique triangle, at 30°, 60° and 90° angles respectively) with route segment lengths between 150 and 300 cm will be marked on the floor and the participants will be asked to complete the task with their eyes closed. The final deviation amount will be recorded.

Intervention type: OTHER
Intervention: Cobb angle measurement
Description: It will be evaluated with the help of X-ray.

Intervention type: OTHER
Intervention: Scolio Detector (mobıl app)
Description: The degree of rotation will be measured with the mobile application called Scolio Detector.
Study: NCT05460390

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM)
Description: Serum trough level of adalimumab and anti-adalimumab antibody will be obtained at time of enrollment and every 3 months until the end of the study. Adalimumab dose optimization goal will be to achieve trough drug level in the range of 5 -8 μg/mL.
Study: NCT06792032

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: peer mentoring with mobile application
Description: peer mentoring with mobile application
Study: NCT06791785

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Before Application
Description: All groups will be asked to fill out forms before the application (Westside test anxiety scale, burdon attention test, descriptive information form)
Study: NCT05022641

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PTeye
Description: The surgeon will first take 5 baseline NIRAF measurements on the thyroid gland (or neck muscle, if thyroid is absent) using the disposable sterile fiber probe that is connected to the PTeye console (see Figure 1), as per device functionality requirements.
Study: NCT06201169

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant placement
Description: All patients received four implants in the lower arch
Study: NCT06791785

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Before Application
Description: All groups will be asked to fill out forms before the application (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Before Application
Description: All groups will be asked to fill out forms before the application (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Before the 1st Written Exam
Description: Fill out forms before the 1st written exam (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Before the 1st Written Exam
Description: Fill out forms before the 1st written exam (Westside test anxiety scale, burdon attention test, descriptive information form)
Study: NCT06201169

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: implant placement
Description: All patients received four implants in the lower arch
Study: NCT06791785

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Before the 1st Written Exam
Description: Fill out forms before the 1st written exam (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: End of Term
Description: Fill out forms at the end of the term (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: End of Term
Description: Fill out forms at the end of the term (Westside test anxiety scale, burdon attention test, descriptive information form)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: End of Term
Description: Fill out forms at the end of the term (Westside test anxiety scale, burdon attention test, descriptive information form)
Study: NCT06791356

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia
Description: 8 sessions of therapy that focus on psychoeducation about sleep hygiene, cognitive restructuring of dysfunctional beliefs that reinforce insomnia, stimulus control to eliminate the association between the bed and wakefulness, sleep restriction in order to establish a consistent sleep schedule, and relaxation training to reduce anxiety that interferes with sleep

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep hygiene education
Description: One session of education about behavioral strategies to optimize sleep quality
Study: NCT06400693

Intervention type: OTHER
Group type: OTHER
Intervention: Endotracheal Intubation
Description: Preparation of all necessary equipment for endotracheal intubation

Intervention type: OTHER
Group type: OTHER
Intervention: Endotracheal Intubation
Description: Preparation of all necessary equipment for endotracheal intubation
Study: NCT05621408

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Training Technique
Description: Attention Training Technique is a six weeks psychological intervention provided by trained professionals
Study: NCT06400693

Intervention type: OTHER
Group type: OTHER
Intervention: Supraglottic Airway
Description: Preparation of all necessary equipment for laryngeal mask

Intervention type: OTHER
Group type: OTHER
Intervention: Supraglottic Airway
Description: Preparation of all necessary equipment for laryngeal mask
Study: NCT05983016

Intervention type: DEVICE
Intervention: Philips EPIQ-7, Philips Healthcare, Bothell, WA, USA
Description: All patients had their abdominal aortic aneurysm maximum anterior-posterior diameter estimated with two-dimensional ultrasound using a 5 MHz curved array transducer (Philips® C5-1 transducer, Philips Healthcare, Bothell, WA, USA).~After the acquisition, a three-dimensional ultrasound acquisition was performed with a 3D-matrix transducer (Philips® X6-1 transducers, Philips Healthcare, Bothell, WA, USA).
Study: NCT04903886

Intervention type: OTHER
Intervention: observational
Description: observational
Study: NCT05459207

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Fat Meal
Description: A liquid meal consisting of powdered protein and complex carbohydrates blended with coconut oil and peanut butter in ratios required to achieve the desired calorie and macronutrient distributions of a normal/moderate fat meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Fat Meal
Description: A liquid meal consisting of powdered protein and complex carbohydrates blended with coconut oil and peanut butter in ratios required to achieve the desired calorie and macronutrient distributions of a normal/moderate fat meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Fat Meal
Description: A liquid meal consisting of powdered protein and complex carbohydrates blended with coconut oil and peanut butter in ratios required to achieve the desired calorie and macronutrient distributions of a high-fat meal.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Fat Meal
Description: A liquid meal consisting of powdered protein and complex carbohydrates blended with coconut oil and peanut butter in ratios required to achieve the desired calorie and macronutrient distributions of a high-fat meal.
Study: NCT06190470

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis product is from the extraction of the powdered, dried and mature pistillate inflorescences of Cannabis sativa L. containing THC 30mg/ml.
Study: NCT05668078

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rapid Antigen Testing (RAT) for COVID-19
Description: COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rapid Antigen Testing (RAT) for COVID-19
Description: COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rapid Antigen Testing (RAT) for COVID-19
Description: COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.
Study: NCT04768595

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two, 1g capsules taken daily with food
Study: NCT06785064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced Food Variety (RFV)
Description: Participants engaged in reduced food variety (RFV) will be asked to choose a few high-calorie, low nutrient main meals and snacks to eat regularly. At the beginning of each month, they will choose one main meal (entrée) to eat at least 2 times a week and one snack food to eat at least 4 times a week within the month. They will have the option to keep or change their main meal and snack options from month to month.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reduced Food Variety (RFV)
Description: Participants engaged in reduced food variety (RFV) will be asked to choose a few high-calorie, low nutrient main meals and snacks to eat regularly. At the beginning of each month, they will choose one main meal (entrée) to eat at least 2 times a week and one snack food to eat at least 4 times a week within the month. They will have the option to keep or change their main meal and snack options from month to month.
Study: NCT04768595

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ceto 10
Description: Two, 1g capsules daily with food

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fish oil
Description: Two, 1g capsules daily with food
Study: NCT06785064

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home-based Resistance Training (HBRT)
Description: Participants assigned to receive home-based resistance training (also called strength training or lifting weights) will be asked to engage in at-home exercises that strengthen muscles at least 2 days each week (≤45 minutes per home session) and track their progress. They will be asked to attend 6, 1-hour group-based skills training workshops (in-person and/or remotely via Zoom) during the first two months of Phase 2 to learn these skills. They will receive exercise plans and equipment (sets of dumbbells, a rack to hold the dumbbells, and an exercise mat) needed to complete exercises.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home-based Resistance Training (HBRT)
Description: Participants assigned to receive home-based resistance training (also called strength training or lifting weights) will be asked to engage in at-home exercises that strengthen muscles at least 2 days each week (≤45 minutes per home session) and track their progress. They will be asked to attend 6, 1-hour group-based skills training workshops (in-person and/or remotely via Zoom) during the first two months of Phase 2 to learn these skills. They will receive exercise plans and equipment (sets of dumbbells, a rack to hold the dumbbells, and an exercise mat) needed to complete exercises.
Study: NCT05575531

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MEWSS and Nursing Guide Application
Description: MEWSS and Nursing Guide application will be used for the patients in the experimental group. According to the Nursing Guide application, patients with MEWS above 4 will be monitored every 5 minutes, while those with a score below 4 will be monitored for 10 minutes. will be followed intermittently. Nursing interventions will be made in accordance with the problems experienced by patients with a score above 4.
Study: NCT05076097

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib in in combination of rituximab and lenalidomide(OLR)
Description: Induction treatment phase: Orelabrutinib: 150mg QD D1-28; Lenalidomide: Cycle 1: 15mg QD D1-21, if no dose-limiting toxicity occurred in Cycle 1, cycle 2-6: 20mg QD D1-21; Cycle 1: 375 mg/m2 d1, 8,15,22; Cycle 3, 5: 375 mg/m2 D1 Maintenance treatment phase: Orelabrutinib: 150mg QD D1-28; Lenalidomide: cycle 7-24: 15mg QD D1-21; Cycle 7, 9, 11, 13, 15, 17, 19, 21, 23: 375 mg/m2 D1. 28 days for a cycle.
Study: NCT06190470

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is similar to Cannabis product but do not contain THC.
Study: NCT05779800

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flowble resin composite stent
Description: Flowble resin composite is a filling material used in operative dentistry and characterized by being flow and easily adapting the surfaces.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: periodontal pack
Description: Non eugenol containing dressing supplied in two tubes
Study: NCT05126511

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Application of CES via ear clips
Description: Use of 100µA CES for one hour per day over PR program

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Application of CES via ear clips
Description: Use of 100µA CES for one hour per day over PR program

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham: No application of CES via ear clips
Description: Use of Sham CES for one hour per day over PR programm

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham: No application of CES via ear clips
Description: Use of Sham CES for one hour per day over PR programm
Study: NCT06090812

Intervention type: OTHER
Intervention: Ultrasound evaluation
Description: Ultrasound evaluation of volume status, right heart function, and pulmonary edema.
Study: NCT04753346

Intervention type: OTHER
Intervention: Physical Activity Level
Description: International Physical Activity Questionnaire

Intervention type: OTHER
Intervention: Physical Activity Level
Description: International Physical Activity Questionnaire

Intervention type: OTHER
Intervention: Physical Activity Level
Description: International Physical Activity Questionnaire

Intervention type: OTHER
Intervention: Physical Activity Level
Description: International Physical Activity Questionnaire

Intervention type: OTHER
Intervention: Anxiety and Depression Assessment
Description: Hospital Anxiety and Depression Scale

Intervention type: OTHER
Intervention: Anxiety and Depression Assessment
Description: Hospital Anxiety and Depression Scale

Intervention type: OTHER
Intervention: Anxiety and Depression Assessment
Description: Hospital Anxiety and Depression Scale

Intervention type: OTHER
Intervention: Anxiety and Depression Assessment
Description: Hospital Anxiety and Depression Scale

Intervention type: DIAGNOSTIC_TEST
Intervention: Exercise Capacity
Description: 6 Minute Walk Test

Intervention type: DIAGNOSTIC_TEST
Intervention: Exercise Capacity
Description: 6 Minute Walk Test

Intervention type: DIAGNOSTIC_TEST
Intervention: Exercise Capacity
Description: 6 Minute Walk Test

Intervention type: DIAGNOSTIC_TEST
Intervention: Exercise Capacity
Description: 6 Minute Walk Test

Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary Function Test
Description: Spirometry
Study: NCT06171815

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scenario-based simulation
Description: Scenario-based simulation prepared for Respiratory Activity and Diabetes Management topics in the course curriculum

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scenario-based simulation
Description: Scenario-based simulation prepared for Respiratory Activity and Diabetes Management topics in the course curriculum
Study: NCT04774952

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RMC-5552
Description: RMC-5552 for IV administration
Study: NCT06070636

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bTAE-HAIC
Description: bTAE procedure was a 2.8-F microcatheter was superselectively inserted into the tumor feeding artery using the coaxial technique. Then blank microspheres were used according to the tumor blood supply vessels (40-120um, 100-300um, 300-500um, 500-700um). The microcatheter was reserved at the proper/left/right hepatic artery according tumor location. After the patient returned to the ward, the following FOLFOX-based regime was intra-arterially administered through the microcatheter. The FOLFOX regimen was administered via the hepatic artery as follows: 85 or 135 mg/m2 oxaliplatin from hour 0 to 2 on day 1, and 400 mg/m2 leucovorin from hour 2 to 4 on day 1, and 400 mg/m2 fluorouracil bolus at hour 5 on the day 1; and 2400 mg/m2 fluorouracil over 46 h on days 1 and 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: 12 mg (or 8 mg) once daily (QD) oral dosing.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg intravenously every 32 weeks
Study: NCT05817981

Intervention type: OTHER
Intervention: Semi-structured interview
Description: Before the questionnaire survey, 30 cancer survivors and 30 clinical oncology medical staff will respectively participate in different semi-structured interview individually.

Intervention type: OTHER
Intervention: Semi-structured interview
Description: Before the questionnaire survey, 30 cancer survivors and 30 clinical oncology medical staff will respectively participate in different semi-structured interview individually.

Intervention type: OTHER
Intervention: Questionnaires set
Description: Except for participants who participated in semi-structured interviews, other cancer survivors who met the inclusion criteria will be asked to respond to the demographic information sheet, the cancer related sexual and reproductive health knowledge and attitudes questionnaire, and the access methods and demand for cancer-related fertility information.